Answers are grounded in this paper and cite their sources.
Malignant ascites is a debilitating condition affecting cancer patients in their terminal stage of disease. Recently, laparoscopic hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) was introduced as a new approach. From September 2001 to August 2008, 52 patients were treated with this new modality. No treatment-related mortality was observed. Median survival was 98 days. One patient developed a clinical recurrence. Laparoscopic HIPEC is a safe and effective method for palliating malignant ascites.
No takes yet. Share an insight, caveat, or question.
Valle et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: